Efficacy and safety of abatacept in patients with rheumatoid arthritis with previous malignancy.

Kunishita, Yosuke; Ichikawa, Kento; Uzawa, Yuji; Mitsuhashi, Masaki; Yoshioka, Yuji; Okubo, Tadanobu; Nagaoka, Shouhei

Kunishita, Yosuke; Ichikawa, Kento; Uzawa, Yuji; Mitsuhashi, Masaki; Yoshioka, Yuji; Okubo, Tadanobu; Nagaoka, Shouhei.

Afiliación

Kunishita Y; Department of Rheumatology, Yokohama Minami Kyosai Hospital, 1-21-1 Mutsuurahigashi, Kanazawa-Ku, Yokohama, Kanagawa 236-0037, Japan.
Ichikawa K; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Uzawa Y; Department of Hematology and Clinical Immunology, Yokohama City University Hospital, Yokohama, Japan.
Mitsuhashi M; Department of Rheumatology, Yokohama Minami Kyosai Hospital, Yokohama, Japan.
Yoshioka Y; Department of Rheumatology, Saiseikai Yokohama-Shi Nanbu Hospital, Yokohama, Japan.
Okubo T; Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Nagaoka S; Department of Rheumatology, Saiseikai Yokohama-Shi Nanbu Hospital, Yokohama, Japan.

Ther Adv Musculoskelet Dis ; 15: 1759720X231186874, 2023.

Article en En | MEDLINE | ID: mdl-37539016

Palabras clave

abatacept; efficacy; previous malignancy; rheumatoid arthritis; safety

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Ther Adv Musculoskelet Dis Año: 2023 Tipo del documento: Article País de afiliación: Japón

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google